BR0208381A - Compostos esteróides, utilização desses compostos para a preparação de medicamentos reguladores de meiose e processo para a preparação desses compostos - Google Patents
Compostos esteróides, utilização desses compostos para a preparação de medicamentos reguladores de meiose e processo para a preparação desses compostosInfo
- Publication number
- BR0208381A BR0208381A BR0208381-7A BR0208381A BR0208381A BR 0208381 A BR0208381 A BR 0208381A BR 0208381 A BR0208381 A BR 0208381A BR 0208381 A BR0208381 A BR 0208381A
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- preparation
- steroid
- meiosis regulating
- meiosis
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- -1 Steroid compounds Chemical class 0.000 title abstract 3
- 230000021121 meiosis Effects 0.000 title abstract 2
- 230000001105 regulatory effect Effects 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 150000003431 steroids Chemical class 0.000 abstract 2
- 229920002472 Starch Polymers 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 210000000287 oocyte Anatomy 0.000 abstract 1
- 125000006850 spacer group Chemical group 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01250108A EP1245572A1 (en) | 2001-03-26 | 2001-03-26 | Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation |
| PCT/EP2002/003148 WO2002079220A2 (en) | 2001-03-26 | 2002-03-20 | Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0208381A true BR0208381A (pt) | 2004-06-15 |
Family
ID=8181575
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0208381-7A BR0208381A (pt) | 2001-03-26 | 2002-03-20 | Compostos esteróides, utilização desses compostos para a preparação de medicamentos reguladores de meiose e processo para a preparação desses compostos |
Country Status (18)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1514874A1 (en) * | 2003-07-28 | 2005-03-16 | Schering Aktiengesellschaft | Thiomorpholino steroid compounds, the use thereof for the preparation of meiosis regulating medicaments and method for the preparation thereof |
| KR100689260B1 (ko) * | 2005-05-24 | 2007-03-02 | 삼원산업주식회사 | 항산화성 스틸벤계 형광증백제 및 이의 합성방법 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1095167A (en) * | 1963-12-05 | 1967-12-13 | Shalom Sarel | Amino-steroids |
| US3419661A (en) * | 1964-01-13 | 1968-12-31 | Univ Missouri | Oral contraceptive for birds |
| DE1643004A1 (de) * | 1967-02-07 | 1971-04-08 | Schering Ag | Bisnorcholenderivate und Verfahren zu ihrer Herstellung |
| DE1930473A1 (de) * | 1969-06-14 | 1970-12-17 | Schering Ag | 22-N-substituierte (20R)-23,24-dinor-cholanderivate |
| US5716777A (en) | 1994-06-23 | 1998-02-10 | Novo Nordisk A/S | Regulation of meiosis using sterols |
| EP0813595A1 (en) * | 1995-03-06 | 1997-12-29 | Novo Nordisk A/S | Stimulation of meiosis |
| ATE254628T1 (de) | 1995-06-23 | 2003-12-15 | Novo Nordisk As | Meiose regulierende verbindungen. |
| EP0946584B1 (en) | 1996-12-20 | 2003-04-23 | Novo Nordisk A/S | Meiosis regulating compounds |
| JP2003522728A (ja) * | 1998-05-13 | 2003-07-29 | ノボ ノルディスク アクティーゼルスカブ | 減数分裂調節化合物 |
| KR20010043828A (ko) | 1998-05-26 | 2001-05-25 | 에바-마리아 시마-메이어, 얼설라 멜져, 마거, 하르트만 | ｃＡＭＰ-증강 화합물 단독 또는 감수분열-자극 화합물하나 이상과의 조합에 의한 불임 치료 방법 |
| EP1156821B1 (en) | 1999-02-24 | 2007-05-02 | Novo Nordisk A/S | Treatment of infertility |
| AU2794100A (en) | 1999-02-24 | 2000-09-14 | Novo Nordisk A/S | Treatment of infertility |
| CN1341147A (zh) | 1999-02-26 | 2002-03-20 | 诺沃挪第克公司 | 减数分裂活化甾醇增大着床率 |
| JP2003509365A (ja) | 1999-09-16 | 2003-03-11 | ノボ ノルディスク アクティーゼルスカブ | Ｉｖｆ用の組成物 |
| AU3376501A (en) | 2000-02-25 | 2001-09-03 | Novo Nordisk A/S | Improvement of implantation rate |
| US6988613B2 (en) * | 2001-02-06 | 2006-01-24 | Novo Nordisk A/S | Composition for IVF |
| ATE386495T1 (de) * | 2001-02-06 | 2008-03-15 | Novo Nordisk As | Behältnis mit niedrigem sauerstoffgehalt, das ff- mas enthält |
-
2001
- 2001-03-26 EP EP01250108A patent/EP1245572A1/en not_active Withdrawn
-
2002
- 2002-03-20 AU AU2002315260A patent/AU2002315260B2/en not_active Ceased
- 2002-03-20 UA UA2003109610A patent/UA75130C2/uk unknown
- 2002-03-20 MX MXPA03008199A patent/MXPA03008199A/es active IP Right Grant
- 2002-03-20 WO PCT/EP2002/003148 patent/WO2002079220A2/en not_active Ceased
- 2002-03-20 HU HU0303643A patent/HUP0303643A2/hu unknown
- 2002-03-20 IL IL15727202A patent/IL157272A0/xx unknown
- 2002-03-20 KR KR10-2003-7012456A patent/KR20030088043A/ko not_active Ceased
- 2002-03-20 BR BR0208381-7A patent/BR0208381A/pt not_active IP Right Cessation
- 2002-03-20 CN CNB028073673A patent/CN1332975C/zh not_active Expired - Fee Related
- 2002-03-20 RU RU2003130228/04A patent/RU2289587C2/ru not_active IP Right Cessation
- 2002-03-20 CZ CZ20032578A patent/CZ20032578A3/cs unknown
- 2002-03-20 CA CA002438210A patent/CA2438210A1/en not_active Abandoned
- 2002-03-20 PL PL02369576A patent/PL369576A1/xx not_active Application Discontinuation
- 2002-03-20 EP EP02740430A patent/EP1401856A2/en not_active Withdrawn
- 2002-03-20 JP JP2002577844A patent/JP2004534011A/ja active Pending
- 2002-03-26 US US10/105,939 patent/US6916921B2/en not_active Expired - Fee Related
-
2003
- 2003-09-25 NO NO20034273A patent/NO20034273L/no not_active Application Discontinuation
- 2003-10-23 ZA ZA200308271A patent/ZA200308271B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US6916921B2 (en) | 2005-07-12 |
| NO20034273L (no) | 2003-11-25 |
| CN1543473A (zh) | 2004-11-03 |
| IL157272A0 (en) | 2004-02-19 |
| JP2004534011A (ja) | 2004-11-11 |
| WO2002079220A2 (en) | 2002-10-10 |
| CN1332975C (zh) | 2007-08-22 |
| US20020188143A1 (en) | 2002-12-12 |
| ZA200308271B (en) | 2005-01-24 |
| UA75130C2 (en) | 2006-03-15 |
| MXPA03008199A (es) | 2004-01-29 |
| KR20030088043A (ko) | 2003-11-15 |
| HUP0303643A2 (hu) | 2004-03-01 |
| RU2289587C2 (ru) | 2006-12-20 |
| RU2003130228A (ru) | 2005-04-10 |
| WO2002079220A3 (en) | 2003-10-16 |
| AU2002315260B2 (en) | 2008-04-03 |
| CZ20032578A3 (cs) | 2003-12-17 |
| PL369576A1 (en) | 2005-05-02 |
| NO20034273D0 (no) | 2003-09-25 |
| EP1401856A2 (en) | 2004-03-31 |
| CA2438210A1 (en) | 2002-10-10 |
| EP1245572A1 (en) | 2002-10-02 |
| HK1070900A1 (en) | 2005-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0108678A (pt) | Novos compostos | |
| BRPI0411255A (pt) | composto, composição farmacêutica, uso de um composto, métodos de tratar um distúrbio de um paciente, e, processo para a preparação de um composto | |
| BR0210711A (pt) | Uso de um composto, composição farmacêutica, composto, e, processo para a preparação de um composto | |
| BRPI0415613A (pt) | novos compostos de diazaspiroalcanos e seu uso no tratamento de doenças mediadas por ccr8 | |
| ATE381537T1 (de) | Formanilid-derivative als beta2-adrenorezeptor- agonisten | |
| BRPI0406427A (pt) | Processo para a preparação de roflumilast | |
| BR0313041A (pt) | Compostos; composições farmacêuticas; método para o tratamento e/ou profilaxia de doenças que estão associadas à modulação dos receptores de cb1; e uso de compostos | |
| BR0309964A (pt) | Derivados anticonvulsivos de sulfamoto substituìdo | |
| BR0307291A (pt) | Composto; processo para a preparação de um composto; composição farmacêutica; uso de um composto; método para o tratamento e profilaxia de distúrbios diversos e de obesidade em um humano | |
| BRPI0410029B8 (pt) | composto dihidroquinazolina substituído, processo para sua preparação, medicamento compreendendo o referido composto e uso do referido composto | |
| BR9911482A (pt) | Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto | |
| BR0313266A (pt) | Compostos, respectivos processos de preparação e uso, formulação farmacêutica e métodos de prevenção e/ou tratamento de um distúrbio mediado pelo receptor de mglur5 e de inibição da ativação de receptores de mglur5 | |
| BRPI0417376A (pt) | compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os compreendem, método para o tratamento e/ou profilaxia de enfermidades que estão associadas com a modulação de receptores de cb1 e sua utilização | |
| BRPI0411508A (pt) | composto, formulação farmacêutica, uso de um composto, método para tratar doenças, e, processo para preparar um composto | |
| BR9912240A (pt) | Benzocicloheptenos, processo para a sua preparação, preparados farmacêuticos, que contêm os mesmos bem como seu emprego para a preparação de medicamentos | |
| ATE330959T1 (de) | Allosterische adenosin-rezeptor-modulatore | |
| BR0317888A (pt) | Cristais do hormÈnio do crescimento humano e processos para preparação dos mesmos | |
| BR0211601A (pt) | Polimorfo estável de flibanserina, processo técnico para a preparação do mesmo e o uso do mesmo para a preparação de medicamentos | |
| AU2002314914A1 (en) | Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases | |
| TNSN04203A1 (en) | Benzoxazinone-derived compounds, their preparation and use as medicaments | |
| BR0306738A (pt) | Processo e aparelho para preparar partìculas cristalinas de uma substância, população de partìculas, e, composição farmacêutica | |
| BRPI0208468B8 (pt) | camsilato de amlodipina e processo para sua preparação | |
| BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes | |
| BR0012610A (pt) | Novo derivado de difenilpiperidina | |
| ATE367387T1 (de) | Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A(S) 8A E 9A ANUIDADE(S) |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2103 DE 26/04/2011. |